BlackRock, Inc.

Position in ALKS — Alkermes plc.

CIK 2012383 New York, NY

Position in ALKS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,531,952,715

+$530,755,188 QoQ

Shares Held

29,235,739

+3.3% QoQ

Ownership

17.4%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 423 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,294,529	$2,868,734,637
2	ZTS	Zoetis Inc.	39,430,181	$2,833,452,797
3	NBIX	Neurocrine Biosciences Inc	13,711,607	$2,310,954,234
4	TEVA	Teva Pharmaceutical Industries Ltd	63,894,301	$2,164,738,910
5	ALKS	Alkermes plc. This page	29,235,739	$1,531,952,715
6	VTRS	Viatris Inc	86,019,468	$1,365,989,144
7	ELAN	Elanco Animal Health Inc	48,849,973	$1,202,197,829
8	HIMS	Hims & Hers Health, Inc.	28,703,514	$995,150,823

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,531,952,715	29,235,739	+3.3%	Shares	Sole	2026-08-07
2026-03-31	$1,001,197,527	28,314,410	+0.1%	Shares	Sole	2026-05-13
2025-12-31	$791,062,077	28,272,412	+1.1%	Shares	Sole	2026-02-12
2025-09-30	$839,162,340	27,972,078	+0.4%	Shares	Sole	2025-11-12
2025-06-30	$796,964,812	27,856,163	+1.6%	Shares	Sole	2025-08-12
2025-03-31	$904,958,262	27,406,368	-1.6%	Shares	Sole	2025-05-02
2024-12-31	$801,049,651	27,852,909	-1.5%	Shares	Sole	2025-02-07
2024-09-30	$791,513,469	28,278,438	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.